Completed
Patient Preference Study of Pazopanib Versus Sunitinib in Advanced or Metastatic Kidney Cancer
NCT01064310
- Conditions
- Adenocarcinoma, Behavior, Carcinoma, +18 more
- Locations
-
- Novartis Investigative Site Helsinki, Finland
- Novartis Investigative Site Joensuu, Finland
- Novartis Investigative Site Lahti, Finland
- Novartis Investigative Site Seinäjoki, Finland